Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-12-040877)

Filing Details

Accession Number:: 0001181431-12-040877
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-07-17 16:10:51
Reporting Period:: 2012-07-13

Filing Date:: 2012-07-17
Accepted Time:: 2012-07-17 16:10:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
906709	Nektar Therapeutics	NKTR	Pharmaceutical Preparations (2834)	943134940

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1227886	Robert Chess	C/O Nektar Therapeutics 455 Mission Bay Boulevard South San Francisco CA 94158		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-07-13	24,001	$6.12	284,624	No	4	M	Direct
Common Stock	Disposition	2012-07-13	24,001	$8.50	260,623	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option	Disposition	2012-07-13	24,001	$0.00	24,001	$6.12

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2007-10-31	2012-10-30	No	4	M	Direct

Footnotes

Stock option exercise and sale executed under an existing trading plan previously adopted by the Reporting Person under Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended. The stock option being exercised expires on October 30, 2012.
This number includes 4,914 shares held by the reporting person in his account under the issuer's 401(k) plan. The acquisition of these shares under the plan is exempt under Rule 16b-3(c).